Zobrazeno 1 - 10
of 797
pro vyhledávání: '"inactivated vaccines"'
Autor:
S. S. Kurashova, M. S. Egorova, M. V. Balovneva, A. N. Vetrova, A. S. Balkina, R. D. Teodorovich, V. G. Petrov, T. K. Dzagurova, E. A. Tkachenko
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 23, Iss 4, Pp 34-43 (2024)
Relevance. Hemorrhagic fever with renal syndrome (HFRS) is leading among natural focal human diseases in Russia, the causative agents of which - orthohantaviruses - belong to the order Bunyavirales, family Hantaviridae. More than 98% of HFRS cases in
Externí odkaz:
https://doaj.org/article/8821f65c84c441e9af5ffc2dda4028e5
Autor:
Ziyu Liu, Liyan Cai, Man Xing, Nan Qiao, Jiaojiao Liu, Xuejun Li, Chiyu Zhang, Naijun Tang, Zhelong Xu, Yingying Guo, Renfei Lu, Dongming Zhou
Publikováno v:
Biosafety and Health, Vol 6, Iss 3, Pp 153-164 (2024)
Inactivated coronavirus disease 2019 (COVID-19) vaccines such as CoronaVac and BBIBP-CorV have been widely used in China. However, more investigation is still needed to understand antibodies' duration and effectiveness against severe acute respirator
Externí odkaz:
https://doaj.org/article/ac43b0f338bb46cabe0a44e5ab86f718
Autor:
Expedito J.A. Luna, José C. Moraes, Manuela A. Roediger, Erique J.F.P. Miranda, Patrícia E. Braga, João I.D. França, Pedro H.M. Pacheco, Marcos Alves de Lima, Lucas Ragiotto, Eliana N.C. Barros
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 28, Iss 5, Pp 103856- (2024)
The present study aimed to evaluate the effectiveness of two doses of CoronaVac in preventing SARS-CoV-2 symptomatic disease with virological confirmation, as well as in the prevention of COVID-19 moderate and severe cases. A test-negative unmatched
Externí odkaz:
https://doaj.org/article/51dde490bde84c0f90745b91df4b8e65
Autor:
Andrey Moiseenko, Yichen Zhang, Mikhail F. Vorovitch, Alla L. Ivanova, Zheng Liu, Dmitry I. Osolodkin, Alexey M. Egorov, Aydar A. Ishmukhametov, Olga S. Sokolova
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTThe main approach to preventing tick-borne encephalitis (TBE) is vaccination. Formaldehyde-inactivated TBE vaccines have a proven record of safety and efficiency but have never been characterized structurally with atomic resolution. We report
Externí odkaz:
https://doaj.org/article/8978a4d1662043f8b42d012a151aac91
Autor:
Evgeny B. Pichkur, Mikhail F. Vorovitch, Alla L. Ivanova, Elena V. Protopopova, Valery B. Loktev, Dmitry I. Osolodkin, Aydar A. Ishmukhametov, Valeriya R. Samygina
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTTick-borne encephalitis virus (TBEV) causes a severe disease, tick-borne encephalitis (TBE), that has a substantial epidemiological importance for Northern Eurasia. Between 10,000 and 15,000 TBE cases are registered annually despite the avail
Externí odkaz:
https://doaj.org/article/c8c766a04fd34eb5b0173f8e54e4a91d
Autor:
Fernando Carlos Ramos‐Espinoza, Victor Alexander Cueva‐Quiroz, Norquis Caled Alvarez‐Rubio, Nicoli Paganoti de Mello, Julieta Rodini Engrácia deMoraes
Publikováno v:
Journal of the World Aquaculture Society, Vol 55, Iss 1, Pp 257-272 (2024)
Abstract Mannan oligosaccharides (MOS) have shown to stimulate immune response in different fish species, but the results may appear contradictory and have not been tested in conjunction with vaccination. We hypothesized that dietary MOS supplementat
Externí odkaz:
https://doaj.org/article/aaa64158e0bd4922b7fe85b538842671
Autor:
B. S. Belov, N. V. Muravyeva
Publikováno v:
Антибиотики и Химиотерапия, Vol 68, Iss 5-6, Pp 77-83 (2023)
The review presents the recommendations of the American College of Rheumatology on vaccination of patients with rheumatic diseases. The indications for vaccination against major infections and the tactics of immunization with inactivated vaccines are
Externí odkaz:
https://doaj.org/article/485542f09b3148dba85b9dd7a05353c9
Autor:
Yangyang Qi, Hui Zheng, Jinxia Wang, Yani Chen, Xu Guo, Zheng Li, Wei Zhang, Jiajia Zhou, Songmei Wang, Boyi Lin, Lin Zhang, Tingting Yan, John Clemens, Jielai Xia, Zhijie An, Zundong Yin, Xuanyi Wang, Zijian Feng
Publikováno v:
Vaccines, Vol 12, Iss 7, p 781 (2024)
Background: Several COVID-19 vaccines were developed and approved in China. Of these, the BIBB-CorV and CoronaVac inactivated whole-virion vaccines were widely distributed in China and developing countries. However, the performance of the two vaccine
Externí odkaz:
https://doaj.org/article/f3e9b538e768462e8fdce1bce65a9d5e
Autor:
Yifeng Luo, Qian Zhou, Xinyan Huang, Yuqi Ding, Xiangrong Ye, Jie Ding, Yukun Kuang, Yihao Liu, Sui Peng, Qingtang Zhu, Haibo Wang, Haipeng Xiao
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Negative conversion of nucleic acid was a key factor in deciding discharge or the end of isolation of asymptomatic or mild COVID-19 patients. We aimed to explore the effect of vaccination on the time to negative conversion after O
Externí odkaz:
https://doaj.org/article/19666f0b0528434eac5641edabb22a19
Autor:
Miao Wang, Bing Zhou, Qing Fan, Xinrong Zhou, Xuejiao Liao, Jingyan Lin, Zhenghua Ma, Jingke Dong, Haiyan Wang, Xiangyang Ge, Bin Ju, Zheng Zhang
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTWith the ongoing COVID-19 pandemic and the emergence of various SARS-CoV-2 variants, a comprehensive evaluation of long-term efficacy of antibody response in convalescent individuals is urgently needed. Several longitudinal studies had report
Externí odkaz:
https://doaj.org/article/3f5baf13e0d8465081d1336e72222f89